Mersana Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Mersana Therapeutics Stock Summary

Mersana Therapeutics competes with Terns Pharmaceuticals, Amylyx Pharmaceuticals, Acumen Pharmaceuticals, Inozyme Pharma, and X4 Pharmaceuticals. Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates for cancer patients with unmet need. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts. Mersana Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 169 people.

Mersana Therapeutics Key Financial Ratios

Mersana Therapeutics Key Balance Sheet Accounts

Mersana Therapeutics Key Income Statement Accounts

Mersana Therapeutics Key Cash Accounts

Mersana Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Mersana Therapeutics's current stock value. Our valuation model uses many indicators to compare Mersana Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mersana Therapeutics competition to find correlations between indicators driving Mersana Therapeutics's intrinsic value. More Info.Mersana Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Mersana Therapeutics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mersana Therapeutics' earnings, one of the primary drivers of an investment's value.

Mersana Therapeutics Systematic Risk

Today, most investors in Mersana Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Mersana Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Mersana Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Mersana Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Mersana Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mersana Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Mersana Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mersana Therapeutics's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mersana Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Mersana Stock, please use our How to Invest in Mersana Therapeutics guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mersana Therapeutics. If investors know Mersana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mersana Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Mersana Therapeutics is measured differently than its book value, which is the value of Mersana that is recorded on the company's balance sheet. Investors also form their own opinion of Mersana Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Mersana Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mersana Therapeutics' market value can be influenced by many factors that don't directly affect Mersana Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mersana Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mersana Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mersana Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.